Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Current Assets (2016 - 2025)

Biomerica's Current Assets history spans 15 years, with the latest figure at $5.2 million for Q4 2025.

  • For Q4 2025, Current Assets fell 12.68% year-over-year to $5.2 million; the TTM value through Nov 2025 reached $5.2 million, down 12.68%, while the annual FY2025 figure was $4.9 million, 36.94% down from the prior year.
  • Current Assets for Q4 2025 was $5.2 million at Biomerica, down from $5.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $15.2 million in Q1 2022 and bottomed at $4.9 million in Q2 2025.
  • The 5-year median for Current Assets is $8.9 million (2021), against an average of $8.8 million.
  • The largest annual shift saw Current Assets surged 87.92% in 2021 before it plummeted 57.44% in 2023.
  • A 5-year view of Current Assets shows it stood at $12.4 million in 2021, then plummeted by 34.71% to $8.1 million in 2022, then increased by 26.75% to $10.3 million in 2023, then tumbled by 42.08% to $5.9 million in 2024, then dropped by 12.68% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Current Assets are $5.2 million (Q4 2025), $5.9 million (Q3 2025), and $4.9 million (Q2 2025).